GIACOMELLI, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 14.012
EU - Europa 7.900
AS - Asia 4.845
SA - Sud America 68
Continente sconosciuto - Info sul continente non disponibili 37
OC - Oceania 28
AF - Africa 16
Totale 26.906
Nazione #
US - Stati Uniti d'America 13.975
IE - Irlanda 2.532
CN - Cina 2.111
TR - Turchia 1.478
SE - Svezia 1.128
SG - Singapore 987
IT - Italia 980
DE - Germania 887
UA - Ucraina 820
GB - Regno Unito 622
FI - Finlandia 358
FR - Francia 301
IN - India 130
VN - Vietnam 63
BR - Brasile 60
BE - Belgio 56
RU - Federazione Russa 45
EU - Europa 34
CA - Canada 28
NL - Olanda 27
RO - Romania 26
CZ - Repubblica Ceca 22
AU - Australia 19
GR - Grecia 17
CH - Svizzera 13
BG - Bulgaria 10
ES - Italia 10
NZ - Nuova Zelanda 9
PT - Portogallo 8
QA - Qatar 8
KR - Corea 7
MY - Malesia 7
DK - Danimarca 6
EG - Egitto 6
JP - Giappone 6
HK - Hong Kong 5
IL - Israele 5
MX - Messico 5
AL - Albania 4
BD - Bangladesh 4
MK - Macedonia 4
PH - Filippine 4
PK - Pakistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AT - Austria 3
ET - Etiopia 3
HR - Croazia 3
HU - Ungheria 3
ID - Indonesia 3
IR - Iran 3
KE - Kenya 3
KW - Kuwait 3
LT - Lituania 3
LU - Lussemburgo 3
PL - Polonia 3
AR - Argentina 2
CO - Colombia 2
LB - Libano 2
LV - Lettonia 2
PE - Perù 2
RS - Serbia 2
ZA - Sudafrica 2
AM - Armenia 1
AZ - Azerbaigian 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EC - Ecuador 1
GE - Georgia 1
HN - Honduras 1
IQ - Iraq 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 26.906
Città #
Jacksonville 3.346
Chandler 2.675
Dublin 2.525
Boardman 992
Santa Clara 934
Izmir 830
Singapore 728
Nanjing 554
San Mateo 512
Wilmington 495
Lawrence 444
Princeton 444
New York 321
Ann Arbor 291
Beijing 261
Nanchang 221
Ashburn 217
L'aquila 164
L’Aquila 161
Milan 161
Dearborn 142
Woodbridge 135
Seattle 125
Shenyang 119
Verona 119
Des Moines 110
Hebei 103
Kunming 90
Tianjin 90
Jiaxing 84
Los Angeles 74
Shanghai 70
Mountain View 65
Dong Ket 60
Changsha 59
Jinan 57
Zhengzhou 56
Norwalk 55
Brussels 50
Helsinki 47
Hangzhou 43
Dallas 38
Ningbo 34
Philadelphia 33
Pune 33
Rome 33
Guangzhou 29
Hefei 29
Kitzingen 21
Lanzhou 21
Munich 20
Brno 19
Houston 18
Bremen 17
Pescara 17
Taizhou 17
Redwood City 16
Bucharest 15
Changchun 14
Frankfurt am Main 14
Fremont 13
Fuzhou 13
Washington 12
Chengdu 11
Phoenix 11
Edinburgh 10
Falls Church 9
Grafing 9
Jinhua 9
Mumbai 9
Doha 8
Moscow 8
Auburn Hills 7
Salerno 7
Cedar Knolls 6
Düsseldorf 6
Forest City 6
La Spezia 6
London 6
Orange 6
Padova 6
Reggio Nell'emilia 6
St Petersburg 6
Tappahannock 6
Amsterdam 5
Athens 5
Auckland 5
Brisbane 5
Montreal 5
Naples 5
Raritan 5
Redmond 5
Stockholm 5
São Paulo 5
Tokyo 5
West Jordan 5
Chicago 4
Columbus 4
Leuven 4
Lisbon 4
Totale 18.739
Nome #
------- 318
EULAR Textbook on Rheumatic Diseases – Third Edition (2018) 258
Aumento dei linfociti circolanti gamma-delta Vdelta1+ in corso di malattie infiammatorie intestinali 132
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 118
Studio dell’espressione della chemochina SDF-1 e del suo recettore CXCR4 nella cute e nelle cellule endoteliali microvascolari di pazienti affetti da sclerosi sistemica (SSc). 110
Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis. 106
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 105
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 103
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 101
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 98
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 98
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 98
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 97
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 97
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 96
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 94
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome. 94
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 93
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: Results of a large multicentre study 90
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 89
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 89
Linfociti T Gamma-Delta (G/D) in pazienti con malattie infiammatorie intestinali (IBD) 88
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 87
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease 86
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 86
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 85
Cytokine production in patients with monoclonal gammapathies. 85
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 84
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 83
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 83
Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis 83
Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population. 83
Stem cell therapies for systemic sclerosis 82
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 82
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 81
Cardiovascular disease in primary sjögren’s syndrome 81
A comprehensive review on adult onset Still's disease 81
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature. 80
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells 80
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 80
Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18. 80
GM-CSF and pregnancy: evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment. 80
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 80
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 80
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 79
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study 79
GAMMA/DELTA T CELL APOPTOSIS IN SYSTEMIC SCLEROSIS PATIENTS 79
Inosine pranobex in the combination therapy of HIV infection. 78
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 78
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 78
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 78
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 78
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 77
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 77
Malattie dell'apparato cardiovascolare 77
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 77
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives. 77
CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment. 76
Combined approach to the initial stage raynaud’s phenomenon diagnosis by means of dynamic digital telehermograpy, capillaroscopy and pletismography. Preliminary findings. 76
Natural killer cell frequency and function in patients with monoclonal gammopathies. 76
The role of cytokines in the patogenesis of monoclonal gammapathies. 76
l'immunoterapia dei tumori 76
Biotech on the Rise: The Treatment of Psoriasis with Biological Drugs 76
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 76
Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization 75
Neoplasie e sistema immune 75
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 75
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 75
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 75
ALTERAZIONI DELLE SOTTOPOLAZIONI LINFOCITARIE IN CORSO DI SCLERODERMIA 75
Unmasking the pathogenic role of il-17 axis in primary sj¨ogren’s syndrome: A new era for therapeutic targeting? 75
The role of cytokines in the pathogenesis of PSS: an overview 75
The expansion of NK CD56+ cells with reduced cytotoxicity in a female patient with systemic sclerosis 74
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. 74
Evidence of drug interaction between cyclosporin A and H2-receptor antagonists (cimetidine, ranitidine and famotidine) in Sprague-Dawley rats. 74
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 73
Combined approach to the initial stage raynaud's phenomenon diagnosis by means of dynamic digital telethermography, capillaroscopy and pletismography preliminary findings. 73
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.. Epub 2002 Aug 30 73
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 73
NK activity and antibody-dependent cellular citotoxicity (ADCC) in inflammatory bowel disease(IBD) 73
Cyclosporin (CyA) and H2 antagonists 73
Immuopathological demonstration of immune reagents in the kidneys of patient with nephrolithiasis 73
Immunosuppressive therapy of vasculitis: current aspects and perspectives 73
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 73
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 73
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 72
Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells 72
Advances in treatment of rheumatoid arthritis 72
DUO Registry Group. Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry. 72
Pollinosi in Abruzzo. Aspetti aerobiologici e clinici, triennio 1988-1990 72
SDF-1/CXCR4 system in microvascular endothelial cells and skin from patients affected by systemic sclerosi 72
AIDS e neoplasie 72
Imbalance of immune functions in progressive systemic sclerosis patients 72
Common Features in Lymphoproliferative Complications in the Course of Primary Sjo‥gren’s Syndrome: Results From a Multicenter Cohort of 1170 Patients 71
Antimyocardial autoimmunity in ischemic coronary disease 71
Vitamin D and systemic lupus erythematosus - The hype and the hope 71
Combination therapy with cyclosporine and methotrexate in patients with earlyrheumatoid arthritis soon inhibits TNFa production without . decreasing TNFa mRNA levels. An in vivo and in vitro stufy 70
Alterations in lymphocyte subpopulations in bronchiolitis 70
Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1. 70
FAS -670 gene promoter polymorphism confers susceptibility to systemic sclerosis 70
Totale 8.549
Categoria #
all - tutte 121.368
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.368


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.855 0 0 0 0 0 0 600 69 493 144 46 503
2020/20213.716 69 453 25 469 485 142 505 24 470 129 758 187
2021/20222.529 134 240 441 174 103 26 21 152 189 131 179 739
2022/20237.628 605 368 158 745 734 854 15 537 3.241 57 213 101
2023/20241.937 418 114 116 257 149 476 33 103 10 81 52 128
2024/20252.749 135 151 757 232 840 631 3 0 0 0 0 0
Totale 27.367